Importantly, aberrant activation of the p53 pathway has previously been reported in both MJD patient brain tissues and transgenic animal disease models [65–69], and elevated p53 level was observed in MJD transgenic mice [65]. Here, TP53 is linked to Spinocerebellar ataxia type 3.